| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680546 | Alzheimer's & Dementia: Translational Research & Clinical Interventions | 2017 | 6 Pages |
Abstract
While well tolerated, nimodipine treatment did not alter PGRN concentrations or secondary outcomes.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Sharon J. Sha, Zachary A. Miller, Sang-won Min, Yungui Zhou, Jesse Brown, Laura L. Mitic, Anna Karydas, Mary Koestler, Richard Tsai, Chiara Corbetta-Rastelli, Sophie Lin, Emma Hare, Scott Fields, Kirsten E. Fleischmann, Ryan Powers, Ryan Fitch,